


Searching News Database: Lipoxygenase
HSMN NewsFeed - 16 Jun 2021
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
HSMN NewsFeed - 7 Nov 2007
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
HSMN NewsFeed - 14 Mar 2007
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
HSMN NewsFeed - 18 Jul 2006
Critical Therapeutics Announces Change in Leadership of Specialty Sales Force
Critical Therapeutics Announces Change in Leadership of Specialty Sales Force
HSMN NewsFeed - 26 Jun 2006
Critical Therapeutics Announces Changes to Management Team and Board of Directors
Critical Therapeutics Announces Changes to Management Team and Board of Directors
Additional items found! 17
Members Archive contains
17 additional stories matching:
Lipoxygenase
(Password required)
Lipoxygenase
(Password required)
